Yi Po International Holding Limited (OTCPK: YBZN)
Health Care · Pharmaceuticals · US
$0.07
-62.23% today · +16425.0% 1Y
Yi Po International Holding Limited (OTCPK: YBZN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.55M and employs 55 people.
Over the last twelve months the share price has gained 16425.0%, trading between 0.00 and 0.48.
Tweenvest scores Yi Po International Holding Limited across four factors: quality 50/100, value 45/100, growth 9/100. Its strongest factor is quality.
YBZN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.55M
- Revenue (TTM)
- $650.40K
- P/E
- 20.75
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 4.69
- 52-week high
- $0.48
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 84.01M
- Employees
- 55
- Next earnings
- —
About Yi Po International Holding Limited
Unified Global Corp. operates as a vertically integrated cannabis company in Canada and the United States. It engages in the cultivation, supply, and retail of hemp/cannabis products. The company was formerly known as China Senior Living Industry International Holding Corporation and changed its name to Unified Global Corp. The company is based in Denver, Colorado.
- ISIN
- US16953U1060
- Listed since
- Dec 31, 1997
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.